✦ LIBER ✦

Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension

✍ Scribed by Keith C. Ferdinand; Richard Weitzman; Marc Israel; Joleen Lee; Das Purkayastha; Edgar A. Jaimes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aliskiren-based dual- and triple-combina

✍ Keith C. Ferdinand; Richard Weitzman; Das Purkayastha; Kanaka Sridharan; Edgar A 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 325 KB

Efficacy and Safety of Combined Use of A

✍ Nathaniel Berman; Thomas Hostetter 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Comparative Efficacy and Safety of Combi

✍ Henry R. Black; Myron H. Weinberger; Das Purkayastha; Joleen Lee; Kanaka Sridhar 📂 Article 📅 2011 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 396 KB

Efficacy and safety of combined use of a

✍ Suzanne Oparil; Steven A Yarows; Samir Patel; Hui Fang; Jack Zhang; Andrew Satli 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 136 KB

Safety and Efficacy of Aliskiren/Amlodip

✍ Alexander V. Murray; Wolfgang Koenig; Juan Garcia-Puig; Samir Patel; Alkaz Uddin 📂 Article 📅 2012 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 170 KB

Comparative efficacy and safety of combi

✍ Myron H. Weinberger; Joseph L. Izzo Jr.; Das Purkayastha; Richard Weitzman; Henr 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 361 KB